iBrands Corporations (IBRC) Signs Definative Agreement to Purchase Green Tree

iBrands Corporation Inc. Signs Definitive Agreement to Purchase Green Tree Syndicate Inc.

Transaction will be the most significant in company history.

iBrands Corporation Inc. (OTC-IBRC) today announced the signing of definitive agreement to acquire Green Tree Syndicate Inc. for a total of 250 million common shares. The transaction is expected to be completed by March 25, 2016.

According to Michael Ogburn, iBrands newly appointed CEO, “The signing of this agreement with Green Tree is a transformational event for iBrands. It fulfills our commitment to create shareholder value by acquiring well-known companies with strong infrastructures and tremendous up-side. This transaction, upon completion, will be the most significant in company history as it will expand our distribution channel into the convenient store markets. Green Tree currently distributes to over 500 C-stores in the Southwest with revenue of $2.5 million. They have been given the green light for another 4,500 stores beginning in the second quarter. This gives us a new platform to distribute our energy drink and vapor products that we are currently selling. We believe the acquisition is consistent with our strategic direction, fits within our retail and outsourcing model, provides new distribution opportunities for our existing products, are financially attractive to shareholders, and will result in annual corporate revenues of approximately $11 million with the Green Tree segment representing 60% of revenues and 55% of profits”, he said.

The main brand that iBrands will acquire is Green Tree’s Agent 009 line of vaping products.

“The stock purchase price of 250 million shares, is inclusive of inventories, will be structured as an asset purchase that results in tax benefits, because the effective purchase price is so low,” said Michael Ogburn. “We anticipate that the addition of Agent 009 will be accretive in the Company’s fiscal 2016, which began on January 1, 2016. We also anticipate improvements in our overall gross margin and EBITDA profiles, and importantly, a substantial increase in our free cash flow as a result of these transactions.”

About iBrands Corporation, Inc.:

Headquartered in Irvine, California, iBrands Corporation, Inc. engages in the manufacture and distribution of Ultra-Premium Vapor Products and Beverages to the Retail and C-Store industries. The company offers a wide variety of Vapor Products, E-Liquids and Natural Beverages that are made in the USA, all branded under the iBrands Products line. For further information, please contact the Company at: www.iBrandscorporation.com

Safe Harbor Statement:

This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company’s most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTCBB website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs.  Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, our 1-A registration statement will generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.

Investor Contact: (949) 440-3232